FRANCISCO J. DE LA
SERNA TORROBA
Profesor asociado de Ciencias de la Salud
Hospital Universitario de la Princesa
Madrid, EspañaPublications en collaboration avec des chercheurs de Hospital Universitario de la Princesa (10)
2016
-
Toxicity and efficacy of busulfan and fludarabine myeloablative conditioning for HLA-identical sibling allogeneic hematopoietic cell transplantation in AML and MDS
Bone Marrow Transplantation, Vol. 51, Núm. 7, pp. 961-966
2013
-
Tratamiento de infecciones fúngicas en pacientes hematológicos de alto riesgo. La respuesta de AmBisome no se modifica con el uso previo de azoles de amplio espectro
Revista Espanola de Quimioterapia, Vol. 26, Núm. 1, pp. 64-69
2011
-
Incidence of cytomegalovirus infection and disease in patients with lymphoproliferative disorders treated with alemtuzumab
Expert Review of Hematology, Vol. 4, Núm. 1, pp. 9-16
-
Lenalidomide is effective as salvage therapy in refractory or relapsed multiple myeloma: Analysis of the Spanish compassionate use registry in advanced patients
International Journal of Hematology, Vol. 93, Núm. 3, pp. 351-360
2010
2006
-
Nonmyeloablative stem cell transplantation is an effective therapy for refractory or relapsed Hodgkin lymphoma: Results of a Spanish prospective cooperative protocol
Biology of Blood and Marrow Transplantation, Vol. 12, Núm. 2, pp. 172-183
2001
-
Allogeneic transplantation of CD34+ -selected cells from peripheral blood in patients with myeloid malignancies in early phase: A case control comparison with unmodified peripheral blood tranplantation
Bone Marrow Transplantation, Vol. 28, Núm. 4, pp. 349-354
-
Favourable effect of the combination of acute and chronic graft-versus-host disease on the outcome of allogeneic peripheral blood stem cell transplantation for advanced haematological malignancies
British Journal of Haematology, Vol. 114, Núm. 3, pp. 544-550
1998
-
Autologous peripheral blood stem cell transplantation for multiple myeloma: A report of 259 cases from the Spanish Registry
Bone Marrow Transplantation, Vol. 21, Núm. 2, pp. 133-140
1997
-
Idarubicin and intermediate dose ARA-C followed by consolidation chemotherapy or bone marrow transplantation in relapsed or refractory acute myeloid leukemia
Leukemia and Lymphoma, Vol. 25, Núm. 3-4, pp. 365-372